Theme: Collaborative strategies to fight human metabolic disorder, obesity, diabetes



28th International Conference on Human Metabolic Health, Diabetes, Obesity, & Endocrinology welcome all participants from all around the globe to Webinar on April 21, 2022.

HUMAN METABOLISM 2022 is an international scientific conference concentrating on obesity, diabetes, and endocrinology with the goal of sharing new research opportunities. The Organizing Committee cordially invites all leading researchers, physicians, obesity specialists, physical therapists, metabolic and bariatric surgeons, Integrated Health Professionals, Registered Dieticians & Nutritionists, Yoga & Fitness Professionals, and business entrepreneurs to attend the event, which is themed "Collaborative strategies to fight human metabolic disorder, obesity, diabaties"

Join us for an unparalleled opportunity to engage and network with world-class experts in the industry to share knowledge, collaborate, and form partnerships.

How we're prioritising your health and safety?

All in-person participants at Human Metabolism 2022 are guaranteed a safe and healthy atmosphere. In regard to COVID-19, we are keeping a careful eye on the situation. COVID-19 information for tourists, as well as preventative tips. In addition, we are working closely with the venue, as well as airline and travel sector liaisons, and have ongoing conversations.

Track 1. Diabetes:

Diabetic people and diabetes complications are on the rise all over the world.    Poor diabetes treatment, whether owing to a lack of understanding, limited access to care, or undetected diseases, is a major source of worry in most countries.
  • COVID-19 and diabetes; post-COVID diabetes
  • Diabetes complications
  • Diabetes and metabolic syndrome.
  • Epidemiology of diabetes
  • Clinical diabetes 
  • Diabetic nutrition and diet
  • Diabetes and cardiology
  • Insulin resistance & insulintherapy

Track 2. Obesity:

Obesity is a complicated condition characterised by a large amount of body fat. Obesity is a medical condition that increases your chance of developing other diseases and health problems, including high blood pressure, heart disease, diabetes, and some malignancies. Obesity is usually caused by a combination of hereditary and environmental factors, as well as individual food and activity decisions. Weight loss can be aided by dietary adjustments, increased physical activity, and behavioural changes.
  • Anti-obesity drugs
  • Genetics and epigenetics of obesity
  • Weight management
  • Obesity & cancer
  • Gynecology & obstetrics
  • Liposuction and weight loss treatments
  • Role of steroids and hormones in obesity

Track 3. Child Nutrition and Obesity:

Childhood nutrition refers to the nutritional requirements of healthy children from 2 to 11 years old. Obesity and weight-related infections are also predicted. This includes eating good protein sources, limiting junk food, and drinking milk and water instead of high-energy beverages, among other things. Childhood obesity is a condition in which a child's health or well-being is affected by excess body fat. Because tools for precisely quantifying body fat are difficult to come by, the diagnosis of obesity is usually predicated on BMI. It has been characterized as a critical public health concern due to the rising prevalence of childhood obesity and its numerous negative health consequences.

Track 4. Diabetes and Weight Loss: 

Obesity prevention is a top goal in the fight against diabetes and other chronic illnesses. According to some obesity specialists, reducing the present levels of obesity may be impossible. Weight loss that is unintended or unexplained can be caused by a variety of factors, includes depression, certain medications, and diabetes.

Track 5. Pediatric Endocrinology: 

Pediatric endocrinology is a clinical subspecialty that deals with issues involving the endocrine organs, such as physical growth and sexual improvement in adolescence, diabetes, and so on. Type 1 diabetes is the most well-known ailment in the globe, accounting for over half of all routine clinical practise. The next most fundamental issue is development issues, particularly those amenable to chemical development therapy.

Track 6. Metabolic Health:

Without using pharmaceuticals,  metabolic health as having optimum blood sugar, triglycerides, high-density lipoprotein (HDL) cholesterol, blood pressure, and waist circumference values. These variables have a direct impact on a person's risk of heart disease, diabetes, and stroke.
  • Culinary medicine
  • Metabolic disease
  • Tissue biology
  • Reverse diabetes
  • Pediatric gerontology

Track 7. Diet & Nutrition:

A well-balanced diet provides the body with critical nutrients. An arrangement of plant and animal-based nutrition can meet the requirements for a regulated eating pattern. A sensible diet regimen provides the necessary vitality and nutrients without causing any harmful side effects or excessive weight gain from eating more food than the body requires. Obesity, heart disease, stroke, cancer, hypertension, diabetes, and malignancies of all forms can all be weakened by following a consistent eating regimen and consuming nutritious foods.
  • Low density lipoproteins
  • Fat burning foods
  • Atkins diet for obese people
  • Consuming fresh fruits & vegetables
  • Dietary approaches for weight loss
  • Vitamins for weight loss
  • Calorie counting
  • Macronutrients and micronutrients

Track 8. Genetics and Epigenetics:

Genetics, metagenomics, epigenetics, and the environment all interact to impact this complicated, inherited trait. Numerous genes affecting the phenotypic have been identified, notably in early-onset severe harm, as a result of increased access to the highest analytical methods for genetic study. The function and probable mechanism of epigenetic variations in mediating environmental effects and perhaps providing future intervention options.
  • Genetic syndromes
  • Epigenetics
  • Hereditary factors
  • Type 2 diabaties
  • Genetic mutations
  • Global methylation and obesity
  • Monogenic obesity
  • Syndromic obesity

Track 9. Advanced Treatment for Diabetes:

People with type 1 diabetes require daily insulin injections for the rest of their lives to control their illness, which puts them at risk of long-term consequences. Immunotherapy has the potential to be an insulin-free option for treating, preventing, and possibly curing this chronic condition.
  • Carbohydrate, fat and protein counting
  • Taking insulin
  • Exercising regularly and maintaining a healthy weight

Track 10. Gynecology and Obstetrics:

Obstetrics and gynaecology are two medical specialities that focus on the female reproductive system in two ways. Obstetrics is concerned with the treatment of pregnant women, their unborn children, labour and delivery, and the postpartum period. The obstetrician ensures that mother and child receive the finest prenatal care possible to ensure that labour and delivery go smoothly and that, if intervention is required, it is done swiftly and safely.

Track 11. Gastroenterology: 

It's a meticulous study of the oesophagus, stomach, bile duct, liver, small intestine, pancreas, colon, rectum, and gallbladder's normal function and abnormalities. This involves a complete grasp of the digestive organs' typical functions, such as material transit through the stomach and intestine, digestion and absorption of nutrients into the body, waste disposal from the system, and the liver's role as a digestive organ. Hepatitis, gastroesophageal reflux disease, peptic ulcer disease, colon polyps, cancer, colitis, nutritional problems, gallbladder, bile disease, Irritable bowel syndrome (IBS), and pancreatitis are all included.
  • Clinical gastroenterology
  • Gastrointestinal cancer symptoms
  • Causes and treatment
  • Gastrointestinal malignancy
  • Advances in gastrointestinal oncology
  • Surgical, endoscopic, and future therapies
  • Gastroesophageal reflux disease
  • Functional GI and motility disorders
  • Bariatric surgery and liver transplantation, 
  • Gastrointestinal surgery

Track 12. Diabetic kidney disease:

Diabetic kidney disease is a condition in which a person's kidney function is decreased as a result of diabetes. This indicates that your kidneys have failed to perform their function of eliminating waste and excess fluid from your body. Loss of sleep, a low appetite, and weakness are all signs of kidney disease.
  • Blood glucose
  • High blood pressure
  • Creatinine level

Track 13. Diabetic Eye Diseases:

These are a group of diseases that affect people who have diabetes.
Diabetic eye disease refers to a set of eye issues that can affect diabetics. Diabetic retinopathy, cataracts, and glaucoma are among the conditions. Furthermore, diabetes can harm your eyes, resulting in blurred vision or even blindness. Mild instances can be managed with proper diabetes control. In severe situations, laser therapy or surgery may be required.
Diabetic retinopathy is a complication of diabetes that damages the eyes. Damage to blood vessels at the rear of the eye, where light-sensitive tissue (retina) is present, causes this condition. Diabetic retinopathy used to have no symptoms or very minor visual issues.
  • Patchy vision
  • Eye pain or redness

Track 14. Diabetes Mellitus:

Insulin-dependent (type 1) and non-insulin-dependent (type 2) diabetes are the two primary forms of diabetes that are caused by these two processes. There will be no or insufficient insulin in type 1 diabetes. There is typically adequate insulin in type 2 diabetes, but the cells on which it should operate are not ordinarily responsive. The following are some of the complications

Track 15. Behavioral Therapy for Obesity:

Obesity has become a major national concern. Obesity's increasing prevalence has coincided with an increase in the prevalence of obesity-related diseases such as type 2 diabetes mellitus (T2DM) and cardiovascular problems (CVD).

Track 16. Oral Diabetes Medications:

Metformin is still the first-line treatment. It decreases blood sugar levels while also lowering the risk of hypoglycemia. Whole fruits including berries, citrus, and apricots, as well as other fruits and drinks, might be harmful to diabetics. Apples can help with your A1C and general health by reducing inflammation and regulating blood pressure. 
  • Metformin 
  • Glucophage XR
  • Pioglitozone
  • Rosiglitozone

Track 17. Endocrinology Diabetes: 

The Endocrine System is a collection of organs that produce and release hormones that help regulate a variety of vital physiological functions, including the body's ability to convert food into energy that drives cells and organs. The endocrine system has an influence on how your heart beats, how your bones and tissues grow, and sometimes even your ability to reproduce. It plays an important role regardless of whether you have diabetes, thyroid disease, developmental problems, sexual dysfunction, or any of the other hormone-related illnesses.
  • Hormone-related disorders
  • Diabetic surgeries
  • Thyroid
  • Various metabolic methods

Track 18. Current Research on Obesity:

Obesity among adults has increased dramatically  during the last 20 years. According to the Health Statistics, one-third of all adults worldwide, or over 100 million individuals, are obese.
  • Probiotics for human health
  • Transplantation for diabetic patients
  • Drug treatments and devices
  • Early diagnosis
  • Use of nanotechnology

Track 19. Obesity and Metabolic Diseases:

A diet heavy in unhealthy fats, calories, and carbohydrates, as well as a lack of regular physical activity, can all contribute to metabolic syndrome risk factors. Insulin resistance develops in overweight persons, which is a hormone that regulates blood sugar levels by forcing sugar into the body's cells, where it is utilised for energy. Blood sugar isn't adequately carried into cells when you're resistant to insulin. High blood sugar levels in the bloodstream result as a result, which is one of the symptoms of type 2 diabetes.
  • Abdominal Obesity
  • High Triglyceride Levels
  • High Blood Pressure
  • Cholesterol Levels
  • Insulin Resistance
  • Polycystic Ovary Syndrome
  • Diabetes Mellitus
  • Impaired Glucose Tolerance
  • Impaired Fasting Glucose

Track 20. Dietary and Lifestyle Changes:

Changes in Diet and Lifestyle adjustments are the backbone of treatment and are critical for long-term weight reduction maintenance. Unfortunately, obesity is a chronic illness for which there is no "short term fix" solution or treatment that is successful for all obese people. Obesity may be treated using a variety of different methods. All treatment plans must include lifestyle changes.


In 2017, the worldwide metabolic disease therapeutics market was valued at USD 49.65 billion, with a CAGR of 7.56 percent projected during the forecast year. The increased incidence of lifestyle illnesses and the increasing need for one-time therapy for metabolic disorders are likely to drive this market's growth. Obesity and diabetes are expected to impact more than half a billion people worldwide by 2040, according to various governments and healthcare organisations throughout the world. Inherited metabolic illnesses are also on the rise as a result of changing lifestyles, which is expected to drive market expansion.

Insights on Diseases:

Diabetes, lysosomal disorders, hypercholesterolemia, obesity, and hereditary metabolic disorders are the diseases that the market is divided under. These diseases are typically passed down from generation to generation owing to a defective gene, and some manifest immediately, such as lysosomal disorders, while others manifest later as a result of ageing. Diabetes, for example, may not be detected until a particular age.

Due to the widespread use of metabolic disease therapies such as anti-diabetic medications and injections to manage blood sugar levels, diabetes was expected to be the largest sector in 2017. In diabetes, it's critical to consume metabolic regulators on a regular basis. As a result of this, it is the most profitable category. Obesity, on the other hand, is anticipated to develop at the quickest rate throughout the projection period.

  • The worldwide metabolic disorder therapeutics market is predicted to reach USD 61.10 billion in 2020, up from USD 56.93 billion in 2019.
  • From 2018 to 2025, the global market for metabolic disease therapies is predicted to increase at a compound yearly growth rate of 7.56 percent, reaching USD 88.93 billion.
  • In 2019, North America held a 41.7 percent share of the global metabolic disorder medicines market. This is due to rising obesity and diabetes rates, expensive healthcare costs, and increased knowledge of metabolic diseases.
USA: The Obesity Society, The American Society for Metabolic and Bariatric Surgery (ASMBS), American Obesity Association, Metabolomics Society, Society for Inherited Metabolic Disorders, Endocrine Society, Canadian Diabetes Association, International Diabetes Federation (IDF), The Mexican Diabetes Federation
Europe:  Spanish Diabetes Society, Joint British Diabetes Society for Inpatient care, Primary Care Diabetes Society, BRITISH DIABETIC ASSOCIATION, The European Foundation for the Study of Diabetes, European Diabetes Forum, European Society for Clinical Nutrition and Metabolism, European Society of Endocrinology
Middle East: Middle East North Africa Metabolic and Bariatric Surgery Society, Saudi Society of Endocrinology and Metabolism, The International Federation for the Surgery of Obesity and Metabolic Disorders, World Obesity Federation, 
Asian countries : Korean Society for the Study of Obesity, Obesity & Metabolic Surgery Society of India, The Obesity Society International Federation for the Surgery of Obesity

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date April 21-21, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View